Live-attenuatedYersinia pestisvaccines

The future of plague vaccines: hopes raised by a surrogate, live-attenuated recombinant vaccine candidate

(2012) Jason A Rosenzweig et al.   Expert Review of Vaccines

A Yersinia pestisYscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice

(2012) Joel Bozue et al.   FEMS MICROBIOLOGY LETTERS

Historical variations in mutation rate in an epidemic pathogen, Yersinia pestis

(2012) Y. Cui et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Construction and screening of attenuated ΔphoP/Q Salmonella typhimuriumvectored plague vaccine candidates

(2012) Donata R. Sizemore et al.   Human Vaccines & Immunotherapeutics

An Encapsulated Yersinia pseudotuberculosis Is a Highly Efficient Vaccine against Pneumonic Plague

(2012) Anne Derbise et al.   PLoS Neglected Tropical Diseases

Progress on plague vaccine development

(2011) Jason A. Rosenzweig et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Investigation of a Researcher's Death Due to Septicemic Plague

(2011) Karen M. Frank et al.   NEW ENGLAND JOURNAL OF MEDICINE

A live attenuated strain of Yersinia pestis KIM as a vaccine against plague

(2011) Wei Sun et al.   VACCINE

Developing live vaccines against plague

(2011) Wei Sun et al.   Journal of Infection in Developing Countries

A Dog-Associated Primary Pneumonic Plague in Qinghai Province, China

(2010) Hu Wang et al.   CLINICAL INFECTIOUS DISEASES

The smpB-ssrA Mutant of Yersinia pestis Functions as a Live Attenuated Vaccine To Protect Mice against Pulmonary Plague Infection

(2010) N. A. Okan et al.   INFECTION AND IMMUNITY

Yersinia pestis with Regulated Delayed Attenuation as a Vaccine Candidate To Induce Protective Immunity against Plague

(2010) W. Sun et al.   INFECTION AND IMMUNITY

A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection

(2010) Petra C.F. Oyston et al.   MICROBIAL PATHOGENESIS

Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity

(2010) Giovanna Morelli et al.   NATURE GENETICS

Prospects for new plague vaccines

(2009) Valentina A Feodorova et al.   Expert Review of Vaccines

D27-pLpxL, an Avirulent Strain of Yersinia pestis, Primes T Cells That Protect against Pneumonic Plague

(2009) F. M. Szaba et al.   INFECTION AND IMMUNITY

Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague

(2009) Ayelet Zauberman et al.   PLoS One

The Role of relA and spoT in Yersinia pestis KIM5+ Pathogenicity

(2009) Wei Sun et al.   PLoS One

The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague

(2009) Avital Tidhar et al.   PLoS One

Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens

(2009) V.A. Feodorova et al.   VACCINE

Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270

(2009) Zhizhen Qi et al.   VACCINE

Biology oftrans-Translation

(2008) Kenneth C. Keiler   Annual Review of Microbiology

Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates

(2008) S. B. Mizel et al.   Clinical and Vaccine Immunology

Current challenges in the development of vaccines for pneumonic plague

(2008) Stephen T Smiley   Expert Review of Vaccines

Immune defense against pneumonic plague

(2008) Stephen T. Smiley   IMMUNOLOGICAL REVIEWS

Braun Lipoprotein (Lpp) Contributes to Virulence of Yersiniae: Potential Role of Lpp in Inducing Bubonic and Pneumonic Plague

(2008) J. Sha et al.   INFECTION AND IMMUNITY

The Cyclic AMP Receptor Protein, CRP, Is Required for Both Virulence and Expression of the Minimal CRP Regulon in Yersinia pestis Biovar microtus

(2008) L. Zhan et al.   INFECTION AND IMMUNITY

A Francisella tularensis Schu S4 Purine Auxotroph Is Highly Attenuated in Mice but Offers Limited Protection against Homologous Intranasal Challenge

(2008) Roger D. Pechous et al.   PLoS One

Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells

(2007) Yoonkyung Do et al.   EUROPEAN JOURNAL OF IMMUNOLOGY